Evotaz is a protease inhibitor that was approved in 2015 it is a combination of darunavir and the booster cobicistat. If you have a history of hepatitis B/C or liver damage please inform your doctor.
Evotaz is a protease inhibitor that was approved in 2015 it is a combination of darunavir and the booster cobicistat. If you have a history of hepatitis B/C or liver damage please inform your doctor.